BPI Labs joins Empower Pharmacy in challenging Eli Lilly’s tirzepatide patent over GLP-1 exclusivity
BPI Labs has announced its collaboration with Empower Pharmacy to challenge Eli Lilly's patent on tirzepatide. Read More »
AG Paxton on Texas suing Eli Lilly: They 'put corporate greed over people’s health'
Ken Paxton, the Attorney General for Texas, has accused Eli Lilly of using illegal kickbacks to influence prescriptions of its drugs for profit, potentially harming taxpayers and public health. Read More »
CEO of Empower Pharmacy: 'The smear campaign against compounded GLP-1s was never about safety'
Shaun Noorian, CEO of Empower Pharmacy, said that recent findings by the U.S. Food and Drug Administration (FDA) indicate that efforts by the pharmaceutical industry to discredit compounding pharmacies were not rooted in safety concerns. Read More »
CEO of Empower Pharmacy on GLP-1 access: 'The system treats compounding like a loophole instead of a lifeline'
Shaun Noorian, CEO of Empower Pharmacy, emphasized the importance of compounded medications for personalized and affordable patient care. Read More »
Iowa board files charges against FarmaKeio, citing FDA and California actions
The Iowa Board of Pharmacy has announced the filing of charges against FarmaKeio, a mail-order compounding pharmacy, citing violations of the federal Food, Drug and Cosmetics Act. Read More »
Pediatrician: 'Large corporations are using the 340B program as a cash cow'
Marion Mass, a pediatrician and co-founder of Free2Care, has raised concerns about the misuse of the 340B Drug Pricing Program by large healthcare corporations. Read More »
Former FTC director on 340B program: ‘Drug discounts are being captured by corporate hospital systems'
David Balto, a former policy director at the Federal Trade Commission (FTC), has raised concerns about the 340B drug discount program, alleging that it is being manipulated by corporate hospital systems and large pharmacies to the detriment of... Read More »
Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'
Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »
National Consumers League announces poll showing support for 340B drug pricing reform
The National Consumers League (NCL) has announced the results of a national Morning Consult poll, which reveals significant public support for comprehensive reforms to the 340B Drug Pricing Program. Read More »
Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'
Gerard Acloque, a doctor at The Florida Concierge Medicine & Wellness, expressed concerns over Eli Lilly's legal actions against compounding pharmacies and telehealth companies producing compounded Tirzepatide. Read More »
Ultimate Health Solutions founder on Patients First: 'Our healthcare system doesn't reward health'
Craig Brockie, founder of Ultimate Health Solutions, has expressed concerns about the priorities of large pharmaceutical companies. Read More »
Empower Pharmacy CEO: Big pharmaceutical companies pay 'to make rules that are in favor' of their company and 'stifle competition'
Shaun Noorian, CEO of Empower Pharmacy, said that the U.S. pharmaceutical industry distorts global drug markets through excessive lobbying and anti-competitive practices. Read More »
National Library of Medicine says compounded medications offer alternatives for patients with unique medical needs
The National Library of Medicine has announced that compounded medications offer therapeutic alternatives for patients with unique medical needs that cannot be met by U.S. Food and Drug Administration (FDA)-approved drugs. Read More »
CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx)
Centene Corporation (NYSE: CNC) announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. Read More »
FDA issues emergency authorization for Pfizer COVID-19 vaccine
The U.S. Food and Drug Administration (FDA) recently issued the first emergency use authorization (EUA) allowing the Pfizer-BioNTech COVID-19 vaccine to be distributed in the U.S., according to a release by the FDA. Read More »
Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »
FDA approves drug for PET scanning for prostate cancer patients
The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »
Southeast Asian nations may prefer China over U.S., RAND study finds
Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »
Fresh Express recalls Caesar Supreme kit over concerns of E. coli contamination
The Food and Drug Administration announced Fresh Express is recalling limited numbers of its Caesar Supreme kit over concerns of E. coli STEC 026 contamination, according to a press release. Read More »
Adams: Pharmacists have key role to play in dealing with hypertension crisis in the U.S.
U.S. Surgeon General Jerome Adams recently released a Call to Action to Control Hypertension, noting the important role of pharmacists beyond simply dispensing prescriptions. Read More »
Alerts Sign-up